Skip to content

Author

L. Namazova-Baranova

We have 2 of 71 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Demographic Window of Opportunities: Clinical and Economic Justification of HPV Vaccination Inclusion in NIS in 2027

The presented predictive and pharmacoeconomic model makes it possible to estimate the scale of lost demographic and financial benefits due to delayed inclusion of HPV vaccination in the National Immunisation Schedule, and mathematically proves the importance of immediate launch of overall vaccination to minimize the st...

L. Namazova-Baranova, M. Fedoseenko · 0 citations
Open access Jul 2026

Pneumococcal infection in the elderly: cost-effectiveness of vaccination to reduce demographic losses

Vaccination of Russian people aged ≥60 years with PCV20 provides the greatest reduction in pneumococcal infection incidence and is highly cost-effective compared to PPV23 vaccination and is cost-effective compared to sequential PCV13/PPV23 vaccination.

A. V. Rudakova, S. Avdeev, L. Namazova-Baranova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.